Tussah silk protein adriamycin sustained release microsphere and preparation method thereof

A technology of tussah silk fibroin and slow-release microspheres, which is applied in the field of biomedicine, can solve the problems of large diameter of microspheres, influence on drug activity and albumin activity, low drug loading rate and embedding rate, and reduce toxic and side effects , the effect of improving efficiency

Inactive Publication Date: 2015-03-25
SUZHOU UNIV
View PDF8 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Chinese invention patent (CN10569609A) prepares albumin doxorubicin granules by ultrasonic atomization method, the particle diameter is large, cross-linking by heating and adding chemical cross-linking agent may affect the activity of the drug and the activity of albumin
The document "Journal of Nano Research, 2014, 27: 75-81" introduces a kind of tussah silk fibroin protein-loaded doxorubicin drug microspheres under different pH condi

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tussah silk protein adriamycin sustained release microsphere and preparation method thereof
  • Tussah silk protein adriamycin sustained release microsphere and preparation method thereof
  • Tussah silk protein adriamycin sustained release microsphere and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0023] Example 1:

[0024] Put 80g of tussah silk in the environment of 98~100℃, put it in the environment containing 5g / L Na 2 CO 3 And 0.0625g / L sodium dodecyl sulfate solution for degumming 3 times, each 30min, the liquor ratio is 1:50. After degumming, tussah silk fibroin was obtained, which was dried at 60°C. The tussah silk fibroin fiber is placed in a saturated lithium thiocyanate solution at a liquor ratio of 1:10, dissolved at 50 ° C ± 2 ° C for 60 min, and the obtained tussah silk fibroin protein solution is loaded into a solution with a molecular weight cut-off of 8 to 10 KDa. In a dialysis bag, dialyzed with deionized water for 4 d, and then centrifuged to obtain a regenerated tussah silk fibroin solution with a mass concentration of about 30 mg / ml, which was placed in a 4°C refrigerator for use.

[0025] Adjust the concentration of tussah silk fibroin protein to 10 mg / ml, configure doxorubicin hydrochloride solution, the concentration is 10 mg / ml; configure c...

Example Embodiment

[0032] Example 2

[0033] Put 120g tussah silk in a stainless steel pot of 4L deionized water, heat it to boiling with an induction cooker, add 0.06% Na 2 CO 3 In the aqueous solution, degumming 3 times, 35min each time, the liquor ratio is 1:60. After degumming, tussah silk fibroin was obtained, which was dried at 60°C. The tussah silk fibroin fiber was placed in a saturated lithium thiocyanate solution at a liquor ratio of 1:10, dissolved at 50 °C ± 2 °C for 70 min, and the obtained tussah silk fibroin solution was loaded into a dialysis with a molecular weight cut-off of 8-10 KDa. In the bag, dialyzed with deionized water for 4 d, and then centrifuged to obtain a regenerated tussah silk fibroin solution with a mass concentration of about 25 mg / ml, which was placed in a 4°C refrigerator for storage for later use.

[0034] Adjust the concentration of tussah silk fibroin to 20 mg / ml, configure doxorubicin hydrochloride solution with a concentration of 10 mg / ml; configure c...

Example Embodiment

[0035] Example 3

[0036] Put 180 grams of tussah silk into 8 L of sodium carbonate aqueous solution with a mass concentration of 0.05%, degumming at 98-100° C. for 0.5 hours, repeat the treatment for 3 times, and obtain pure tussah silk fibroin after thorough washing. The dried tussah silk fibroin fiber was heated and dissolved with 1 liter of lithium thiocyanate solution with a concentration of 9.3 mol / liter at 55±5° C. to obtain a mixed solution of tussah silk fibroin protein. Using a cellulose membrane as a dialysis material, the obtained tussah silk fibroin mixed solution was dialyzed with deionized water for 3 days to obtain a pure tussah silk fibroin solution.

[0037] Adjust the concentration of tussah silk fibroin protein to 30 mg / ml, configure doxorubicin hydrochloride solution, the concentration is 10 mg / ml; configure calcium gluconate solution, the concentration is 100 mmol per liter; add doxorubicin hydrochloride solution to tussah silk fibroin solution Mechanica...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
The average particle sizeaaaaaaaaaa
Concentrationaaaaaaaaaa
Diameteraaaaaaaaaa
Login to view more

Abstract

The invention discloses a tussah silk protein adriamycin sustained release microsphere and a preparation method thereof. The tussah silk protein adriamycin sustained release microsphere takes calcium ions as an inducer, natural tussah silk proteins as a shell and adriamycin as nano particles of a core, is uniform in distribution of particle sizes, has the diameter of about 500 nanometers and is biodegradable. According to the tussah silk protein adriamycin sustained release microsphere and the preparation method disclosed by the invention, as the preparation environment of the tussah silk protein adriamycin sustained release microsphere is in a neutral and normal pressure and temperature state, an organic solvent is avoided, and the utilization degree of a medicament is increased; with the tussah silk proteins as an embedding material of the adriamycin, the tussah silk protein adriamycin sustained release microsphere has an RGD sequence and is capable of promoting cells to identify the tussah silk protein adriamycin sustained release microsphere and improving the targeting property of an adriamycin medicament; compared with free adriamycin, the adriamycin embedded in the tussah silk protein microsphere is obvious in sustained release property, expresses pH sensitivity, is obvious in sustained release effect in the environment with a pH value of 5.2, is small in releasing speed under the neutral condition, is convenient for a medicament to be released after entering cancer cells and is capable of remarkably lowering the toxic and side effects in normal cells.

Description

technical field [0001] The invention relates to a drug-loaded microsphere and a preparation method thereof, in particular to a microsphere prepared from tussah silk fibroin-doxorubicin hydrochloride as a raw material and a preparation method thereof, belonging to the technical field of biomedicine. Background technique [0002] Malignant tumor is a common and frequently-occurring disease that seriously threatens human health. At present, there is no effective prevention and control measure. The main method of clinical treatment of cancer is radiotherapy and chemotherapy, but the antitumor drugs used in chemotherapy have serious toxic and side effects on normal organs of the human body. The targeted drug delivery system delivers the drug directly to the lesion site through the carrier material to exert its curative effect. It has the advantages of strong specificity, low toxicity and side effects, improved drug efficacy, reduced drug dose and frequency of administration, etc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/16A61K31/704A61K47/48A61P35/00
Inventor 王娟卢神州殷祝平邢铁玲
Owner SUZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap